Stephen J. Tulipano, CFO at Stoke Therapeutics, Inc. (STOK), sold 4,116 shares at $6.10 ($25K) on 2024-03-19, disclosed to the SEC on 2024-03-19.
Open-market sale of $25k STOK by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ALDX | BUY | 2017-02-21 | $15K | — | Filing → |
| JAV | SELL | 2010-05-05 | $5K | — | Filing → |